McCarthy Daniel Joseph, PRES, reported a transaction classified as grant at Evolent Health, Inc. involving 87585.000000 shares for an estimated $0.00. Reported holdings after the transaction were 417465.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
Form 4 relationship flags and nearby filing context
PRESIDENT
This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.
Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
Represents restricted stock units granted to Mr. McCarthy pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
Securities vest at a rate of 34% on March 3, 2026, and 33% on March 3, 2027, and March 3, 2028.
Represents the number of shares received upon the settlement of the performance-based share units (PSUs) awarded to the reporting person on March 1, 2022, following the certification of
achievement of specified performance metrics by the Compensation Committee of the Company's Board of Directors on March 3, 2025. The shares underlying the PSU award vested at the conclusion of
the performance period on December 31, 2024.
This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon settlement of performance-based share units.
0 other filings
0 recent txs